These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
475 related items for PubMed ID: 406
1. Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver. Leighton F, Coloma L, Koenig C. J Cell Biol; 1975 Nov; 67(2PT.1):281-309. PubMed ID: 406 [Abstract] [Full Text] [Related]
6. Identification of a catalase-negative sub-population of peroxisomes induced in mouse liver by clofibrate. Klucis E, Crane DI, Hughes JL, Poulos A, Masters CJ. Biochim Biophys Acta; 1991 Jul 08; 1074(2):294-301. PubMed ID: 1676600 [Abstract] [Full Text] [Related]
7. Rat liver peroxisomes. I. New peroxisome population induced by thyroid hormones in the liver of male rats. Just WW, Hartl FU, Schimassek H. Eur J Cell Biol; 1982 Feb 08; 26(2):249-54. PubMed ID: 6121707 [Abstract] [Full Text] [Related]
8. Effect of clofibrate application on morphology and enzyme content of liver peroxisomes. Goldenberg H, Hüttinger M, Kampfer P, Kramar R, Pavelka M. Histochemistry; 1976 Feb 26; 46(3):189-96. PubMed ID: 1248951 [Abstract] [Full Text] [Related]
9. Unusual responses of rat hepatic and renal peroxisomes to RMI 14, 514, a new hypolipidemic agent. Svoboda DJ. J Cell Biol; 1978 Sep 26; 78(3):810-22. PubMed ID: 29903 [Abstract] [Full Text] [Related]
11. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response. Reddy JK, Azarnoff DL, Svoboda DJ, Prasad JD. J Cell Biol; 1974 May 26; 61(2):344-58. PubMed ID: 4208071 [Abstract] [Full Text] [Related]
12. Influence of subtotal hepatectomy on peroxisomes and peroxisomal enzymes of rat liver and isolated liver cell fractions. Goldenberg H, Hüttinger M, Böck P, Kramar R. Histochemistry; 1975 Jul 16; 44(1):47-56. PubMed ID: 52639 [Abstract] [Full Text] [Related]
13. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes. Moody DE, Reddy JK. Am J Pathol; 1978 Feb 16; 90(2):435-46. PubMed ID: 623209 [Abstract] [Full Text] [Related]
14. Liver peroxisomal fatty acid oxidizing system during aging in control and clofibrate-treated mice. Périchon R, Bourre JM. Biochem Mol Biol Int; 1995 Oct 16; 37(3):475-80. PubMed ID: 8595387 [Abstract] [Full Text] [Related]
15. The effect of clofibrate on amphibian hepatic peroxisomes. Ciolek E, Dauça M. Biol Cell; 1991 Oct 16; 71(3):313-20. PubMed ID: 1681969 [Abstract] [Full Text] [Related]
16. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB. Reddy J, Svoboda D, Azarnoff D. Biochem Biophys Res Commun; 1973 May 15; 52(2):537-43. PubMed ID: 4711169 [No Abstract] [Full Text] [Related]
17. Changes in peroxisomes and mitochondria in liver of ethionine exposed rats: a biochemical and morphological investigation. Aarsaether N, Aarsland A, Kryvi H, Nilsson A, Svardal A, Ueland PM, Berge RK. Carcinogenesis; 1989 Jun 15; 10(6):987-94. PubMed ID: 2498002 [Abstract] [Full Text] [Related]
20. The synthesis and turnover of rat liver peroxisomes. I. Fractionation of peroxisome proteins. Leighton F, Poole B, Lazarow PB, De Duve C. J Cell Biol; 1969 May 15; 41(2):521-35. PubMed ID: 4389026 [Abstract] [Full Text] [Related] Page: [Next] [New Search]